This website is intended for journalists outside the US/UK, who are interested in media information from Boehringer Ingelheim.

Top Stories



    ASCO 2014: Giotrif® (afatinib) analysis presented


    ASCO 2014: New data presented

    Events and Initiatives

    ASCO 2014

    30 May - 3 June 2014
    ASCO 2014: Boehringer Ingelheim presented latest oncology research, including overall survival results for Giotrif® (afatinib) in advanced NSCLC

    Education Hub



    Professor James Chih-Hsin Yang
    Lux-Lung 3 and Lux-Lung 6 :
    study design



    Nintedanib* Lume-Lung
    1 Clinical Trial


    Afatinib* Lux-Lung 3 & 6
    Clinical Trials

    Tweets from @Boehringer